Press release
At 4.4% CAGR, Hospital Infection Therapeutics Market to Reach USD 3490 Million by 2023: Pfizer, Merck, Bayer, AstraZeneca, Johnson & Johnson Services, Actavis, Sanofi, GlaxoSmithkline
Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infections.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1253936/
The hospital infection therapeutics market is increasing at a significant rate, due to high susceptibility of neonatal population in healthcare setting and high occurrence of numerous hospital infections. Increasing incidences of hospital infections, high number of pipeline drug molecules for specific treatment of healthcare associated infections and high unaddressed needs in most of the countries are some of the factors providing ample opportunities for the hospital infection therapeutics market to grow in the coming years.
North America led the demand for hospital infection therapeutics market in 2017. The high prevalence of nosocomial infections has been identified as the key factor that has been driving the demand for infection therapeutics in North America and is projected to continue to do so throughout the forecast period. Although North America will remain the leading regional market for hospital infection therapeutics, it is Asia Pacific, which will present the most promising growth opportunities to this market in the near future.
The global Hospital Infection Therapeutics market is valued at 2700 million USD in 2017 and is expected to reach 3490 million USD by the end of 2023, growing at a CAGR of 4.4% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital Infection Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Scope of the Report:
This report focuses on the Hospital Infection Therapeutics Market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Hospital Infection Therapeutics Market Segment by Top Manufacturers Including:
• Bayer
• Johnson & Johnson Services
• Actavis
• Sanofi
• Bristol Myers Squibb Company
• AstraZeneca
• Pfizer
• Merck
• GlaxoSmithkline
• Cubist Pharmaceuticals
Hospital Infection Therapeutics Market Segment by Regions, regional analysis covers:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Hospital Infection Therapeutics Market Segment by Type covers
• Antibacterial Drugs
• Antiviral Drugs
• Antifungal Drugs
Market Segment by Applications can be divided into:
• Hospital Acquired Pneumonia
• Surgical Site Infections
• Urinary Tract Infection
• Gastrointestinal Disorders
• Bloodstream Infections
• Others
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1253936/
There are 15 Chapters to deeply display the global Hospital Infection Therapeutics market.
Chapter 1, to describe Hospital Infection Therapeutics Market Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hospital Infection Therapeutics, with sales, revenue, and price of Hospital Infection Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hospital Infection Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hospital Infection Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hospital Infection Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents:
1 Hospital Infection Therapeutics Market Overview
1.1 Product Overview and Scope of Hospital Infection Therapeutics
1.2 Classification of Hospital Infection Therapeutics by Types
1.3 Global Hospital Infection Therapeutics Market by Application
1.4 Global Hospital Infection Therapeutics Market by Regions
2 Manufacturers Profiles
3 Global Hospital Infection Therapeutics Market Competition, by Players
4 Global Hospital Infection Therapeutics Market Size by Regions
10 Global Hospital Infection Therapeutics Market Segment by Type
10.1 Global Hospital Infection Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Hospital Infection Therapeutics Market Forecast by Type (2018-2023)
10.3 Antibacterial Drugs Revenue Growth Rate (2013-2023)
10.4 Antiviral Drugs Revenue Growth Rate (2013-2023)
10.5 Antifungal Drugs Revenue Growth Rate (2013-2023)
11 Global Hospital Infection Therapeutics Market Segment by Application
11.1 Global Hospital Infection Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Hospital Infection Therapeutics Market Forecast by Application (2018-2023)
11.3 Hospital Acquired Pneumonia Revenue Growth (2013-2018)
11.4 Surgical Site Infections Revenue Growth (2013-2018)
11.5 Urinary Tract Infection Revenue Growth (2013-2018)
11.6 Gastrointestinal Disorders Revenue Growth (2013-2018)
11.7 Bloodstream Infections Revenue Growth (2013-2018)
11.8 Others Revenue Growth (2013-2018)
12 Global Hospital Infection Therapeutics Market Size Forecast (2018-2023)
12.1 Global Hospital Infection Therapeutics Market Size Forecast (2018-2023)
For more information on this report at: https://www.marketstudyreport.com/reports/global-hospital-infection-therapeutics-market-2018-by-manufacturers-countries-type-and-application-forecast-to-2023/?utm_source=Openpr.com-SP
Related Report:
Asia-Pacific Hospital Infection Therapeutics Market Report 2017
In this report, the Asia-Pacific Hospital Infection Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
https://www.marketstudyreport.com/reports/asia-pacific-hospital-infection-therapeutics-market-report-2017?utm_source=OpenprRR-SP
About Us:
Market study report LLC allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release At 4.4% CAGR, Hospital Infection Therapeutics Market to Reach USD 3490 Million by 2023: Pfizer, Merck, Bayer, AstraZeneca, Johnson & Johnson Services, Actavis, Sanofi, GlaxoSmithkline here
News-ID: 1489828 • Views: …
More Releases from marketstudyreport.com
Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Powe …
A concise assortment of data on the 'Load Bank Market' offers an exhaustive study targeting current market trends influencing the business across assorted regions. Significant details related to market size, market share, applications, and statistics are put together to convey an ensemble prediction of the industry. The research further focuses on comprehensive competitor analysis in addition to highlighting growth strategies embraced by market leaders.
Load Bank Market Size was estimated…
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - J …
Global Agriculture Equipment Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of the market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
Global Agriculture Equipment Market Size was estimated at USD 114110 million in 2021 and is projected to reach USD 161640 million by 2028, exhibiting a CAGR of…
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc. …
Global Electric Vehicle Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
The electric vehicles (EVs) market is estimated to witness a robust growth rate of 23.5% during the period 2019-2028.
The operation is done to stop ligament tears and…
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - …
Global Fuel Cell Air Compressor Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
Global Fuel Cell Air Compressor Market Size was estimated at USD 215.1 million in 2021 and is projected to reach USD 512.3 million by 2028, exhibiting…
More Releases for Infection
Growing Hospital-Acquired Infection Rates Boost Demand For Infection Prevention …
The Infection Prevention Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Infection Prevention Market?
In the past few years, there has been a consistent increase in the size of the infection prevention market. It is predicted that this market…
Prominent Infection Prevention Market Trend for 2025: Strategic Staffing Innovat …
What Are the Projected Growth and Market Size Trends for the Infection Prevention Market?
The infection prevention market is expected to grow from $43.4 billion in 2024 to $45.01 billion in 2025, reflecting a CAGR of 3.7%. Growth drivers include increasing awareness of healthcare-associated infections (HAIs), stringent regulatory guidelines, technological advancements, and globalization.
The Infection Prevention market is expected to grow to $52.2 billion by 2029 at a CAGR of 3.8%, driven…
Yeast Infection Treatment Market Report 2024 - Yeast Infection Treatment Market …
"The Business Research Company recently released a comprehensive report on the Global Yeast Infection Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The yeast infection…
Combating Infection: Nontuberculous Mycobacterial Infection Market Analysis 2024 …
The nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to improved diagnostics, aging population, cystic fibrosis awareness, immunosuppressive medications.
The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few…
Infection Surveillance Solutions Market: Empowering Infection Prevention | BD, B …
Allied Market Research analysts have recently introduced a new research study titled "Infection Surveillance Solutions Market- Global Outlook and Forecast 2023-2030." The report offers detailed insights and highlights key players in the industry, including Atlas Medical Software, Becton, Dickinson and Company, Baxter International, GOJO Industries, Deb Group, RL Solutions, HyGreen, Wolters Kluwer, Premier, and Truven Health Analytics. This comprehensive study provides in-depth and clear analysis, encompassing market definitions, classifications, manufacturing…
Infection Prevention & Control Market 2026: Product Overview and Scope of Infect …
Infection Prevention & Control Market Research Report and Forecast to 2019-2026 Report provide an extensive research on the fast-evolving Infection Prevention & Control Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2026.
The report mainly studies the size, recent trends and development status of the Infection Prevention & Control market, as well as investment opportunities, government policy, market dynamics (drivers,…
